Literature DB >> 31589952

A systematic review showed more consideration is needed when conducting nonrandomized studies of interventions.

Paula Dhiman1, Hopin Lee2, Shona Kirtley3, Gary S Collins4.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the methodological conduct, reporting, and risk of bias of nonrandomized studies of interventions (NRSIs) funded by UK National Institute for Health Research Biomedical Research Centres (NIHR-BRCs). STUDY DESIGN AND
SETTING: We conducted a systematic review, searching the Medline and Web of Science databases between 2012 and 2018, for NRSIs funded by NIHR-BRCs. Eligible studies were published between April 2012 and December 2017. We selected a contemporary subset of NRSIs published in 2017. We extracted study design, methods for overcoming confounding bias from nonrandomization, analysis methods, and items for assessing risk of bias. Risk of bias was the primary outcome, assessed using Risk Of Bias In Non-randomised Studies-of Interventions (ROBINS-I).
RESULTS: Fifty-two NSRI publications were included, of which over half were cohort studies and 29% before-and-after studies. Seventy-seven percent analyzed nonpurposefully collected data. All had serious or critical risk of bias. Regression adjustment was most commonly used to address confounding bias (50%). Few (12%) studies accounted for missing data and 42% reported different numbers of outcomes in their methods and results.
CONCLUSION: Most reviewed NRSIs had serious or critical risk of bias. Although NRSIs can evaluate treatment effects when appropriately conducted, this review shows that their design, analysis, and reporting require more consideration. Crown
Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Keywords:  Methodology; Nonrandomized; Observational; Reporting; Risk of bias; Systematic review

Year:  2019        PMID: 31589952     DOI: 10.1016/j.jclinepi.2019.09.027

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  2 in total

1.  Cochrane's risk of bias tool for non-randomized studies (ROBINS-I) is frequently misapplied: A methodological systematic review.

Authors:  Erik Igelström; Mhairi Campbell; Peter Craig; Srinivasa Vittal Katikireddi
Journal:  J Clin Epidemiol       Date:  2021-08-23       Impact factor: 6.437

2.  Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis.

Authors:  Phulen Sarma; Hardeep Kaur; Harish Kumar; Dhruv Mahendru; Pramod Avti; Anusuya Bhattacharyya; Manisha Prajapat; Nishant Shekhar; Subodh Kumar; Rahul Singh; Ashutosh Singh; Deba Prasad Dhibar; Ajay Prakash; Bikash Medhi
Journal:  J Med Virol       Date:  2020-05-03       Impact factor: 20.693

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.